GlassScriptPhysician profile
Cassandra J Kaiser-Barrow
NPI 1043881683
$1,802.38
in general payments reported to CMS, 2019-2025
22 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $141 · 2023: $558 · 2024: $494 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.48 | 2023-2025 | |
| Inari Medical, INC. | $151.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Emd Serono, INC. | $124.99 | 2023 | |
| Avanir Pharmaceuticals, INC. | $122.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $122.01 | 2024-2025 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $119.99 | 2023 | Rexulti |
| Sage Therapeutics, LLC | $111.92 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $90.95 | 2025 | Iqirvo |
| Sk Life Science, INC. | $86.06 | 2022 | |
| Novo Nordisk INC | $85.10 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Alkermes, INC. | $68.44 | 2023 | Lybalvi |
| Biogen, INC. | $68.13 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $58.25 | 2021 | |
| Acadia Pharmaceuticals INC | $55.30 | 2022 | |
| Nevro Corp. | $49.91 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $48.18 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $44.75 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $35.35 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $31.32 | 2024 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $23.96 | 2024 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $21.40 | 2024 | |
| Corcept Therapeutics | $19.71 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Kaiser-Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.